KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. (2017)
Attributed to:
Gene-expression connectivity mapping and its application in phenotypic targeting
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.13884
PubMed Identifier: 27965461
Publication URI: http://europepmc.org/abstract/MED/27965461
Type: Journal Article/Review
Volume: 8
Parent Publication: Oncotarget
Issue: 2
ISSN: 1949-2553